Avid Bioservices to be Acquired by GHO and Ampersand Capital Partners for $1.1 Billion Cash Deal

Avid Bioservices, Inc. (CDMO) entered a merger agreement on November 6, 2024, to be acquired by funds managed by GHO Capital Partners and Ampersand Capital Partners in a deal valued at $1.1 billion.

Details of the Agreement:

As per the merger agreement, GHO and Ampersand would acquire all the outstanding shares held by Avid’s stockholders for $12.50 per share in cash, representing a 13.84% premium from the stock’s last close.

Please subscribe for free or login to your InsideArbitrage account to access this article.